GAMMA Investing LLC Raises Position in Enhabit, Inc. (NYSE:EHAB)

GAMMA Investing LLC raised its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 3,373.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,055 shares of the company's stock after buying an additional 30,161 shares during the period. GAMMA Investing LLC owned about 0.06% of Enhabit worth $273,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in EHAB. PharVision Advisers LLC bought a new stake in Enhabit in the 4th quarter worth $317,000. Squarepoint Ops LLC purchased a new stake in shares of Enhabit during the fourth quarter worth about $185,000. Two Sigma Advisers LP grew its stake in shares of Enhabit by 40.1% in the fourth quarter. Two Sigma Advisers LP now owns 27,600 shares of the company's stock worth $216,000 after purchasing an additional 7,900 shares during the last quarter. State of Wyoming raised its position in Enhabit by 95.7% during the 4th quarter. State of Wyoming now owns 71,307 shares of the company's stock valued at $557,000 after purchasing an additional 34,861 shares during the last quarter. Finally, Systematic Financial Management LP lifted its holdings in Enhabit by 8.6% in the 4th quarter. Systematic Financial Management LP now owns 1,996,113 shares of the company's stock worth $15,590,000 after buying an additional 157,914 shares during the period.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Trading Down 0.9%

NYSE:EHAB opened at $9.26 on Friday. The company has a 50-day moving average price of $9.37 and a 200-day moving average price of $8.66. The stock has a market cap of $468.67 million, a price-to-earnings ratio of -3.34 and a beta of 1.80. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $10.91.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.07 by $0.03. Enhabit had a negative net margin of 13.43% and a positive return on equity of 2.02%. The business had revenue of $259.90 million during the quarter, compared to analyst estimates of $266.11 million. Equities analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.